. "Appendix B: Public Meeting Agenda, February 9, 2004." Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press, 2004.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Immunization Safety Review: Vaccines and Autism
Appendix B
Public Meeting Agenda February 9, 2004
Immunization Safety Review Vaccines and Autism
National Academy of Sciences Building
Auditorium, 2100 C Street, NW
Washington, DC
8:00–8:15 am
Welcome and Opening Remarks
Marie McCormick, M.D., Sc.D., Committee Chair
8:15–8:30 am
Congressional Speakers
Congressman Dave Weldon,
U.S. House of Representatives
8:30–9:30 am
Etiologic Factors and Pathogenesis of Autism: Evidence from Clinical Studies and Animal Models
Mady Hornig, M.D., Associate Professor,
Columbia University Mailman School of Public Health
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole. Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 180
Immunization Safety Review: Vaccines and Autism
Appendix B
Public Meeting Agenda February 9, 2004
Immunization Safety Review Vaccines and Autism
National Academy of Sciences Building
Auditorium, 2100 C Street, NW
Washington, DC
8:00–8:15 am
Welcome and Opening Remarks
Marie McCormick, M.D., Sc.D., Committee Chair
8:15–8:30 am
Congressional Speakers
Congressman Dave Weldon,
U.S. House of Representatives
8:30–9:30 am
Etiologic Factors and Pathogenesis of Autism: Evidence from Clinical Studies and Animal Models
Mady Hornig, M.D., Associate Professor,
Columbia University Mailman School of Public Health
OCR for page 181
Immunization Safety Review: Vaccines and Autism
9:30–10:00 am
Association of Autistic Spectrum Disorder and MMR Vaccine: A Systematic Review of Current Epidemiological Evidence
Kumanan Wilson, M.D., M.Sc., Division of Clinical Decision Making and Health Care, Toronto General Research Institute, Canada
10:00–10:30 am
Age at First Measles-Mumps-Rubella Vaccination in Children with Autism and School-Matched Control Subjects
Frank DeStefano, M.D., Centers for Disease Control and Prevention
10:30–10:45 am
Break
10:45–11:15 am
Exposure to Thimerosal-Containing Vaccines in U.K. Children and Autism
Dr. Elizabeth Miller, Head, Immunisation Division, Public Health Laboratory Service, Communicable Disease Surveillance Centre, London
11:15–11:45 am
Vaccine Safety Datalink Study: Autism Outcome
Robert L. Davis, M.D., M.P.H., University of Washington Group Health, Cooperative Departments of Pediatrics Center for Health Studies and Epidemiology
11:45–12:15 pm
Study of the Association Between Thimerosal-Containing Vaccine and Autism in Denmark
Anders Peter Hviid, M.Sc., Department of Epidemiology Research, State Serum Institute, Copenhagen, Denmark
12:15–12:45 pm
Autism and Thimerosal-Containing Vaccines: Analysis of the Vaccine Adverse Events Reporting System (VAERS)
Mark R. Geier, M.D., Ph.D., President, The Genetic Centers of America
David Geier, President of MedCon
12:45–1:45 pm
Lunch
OCR for page 182
Immunization Safety Review: Vaccines and Autism
1:45–2:15 pm
A Toxicologist’s View of Thimerosal and Autism
H. Vasken Aposhian, Ph.D., Professor, Molecular and Cellular Biology, University of Arizona
2:15–2:45 pm
Relation of Neurotoxic Effects of Thimerosal to Autism
David Baskin, M.D., Professor of Neurosurgery and Anesthesiology, Baylor College of Medicine
2:45–3:15 pm
Thimerosal Exposure from Vaccines and Ethylmercury Accumulation in Nonhuman Primates
Dr. Polly Sager, Assistant Director for International Research, National Institute of Allergy and Infectious Diseases
3:15–3:30 pm
Break
3:30–4:00 pm
Reduced Levels of Mercury in First Baby Haircuts of Autistic Children
Boyd Haley, Ph.D., Chairman and Professor, Department of Chemistry, University of Kentucky
4:00–4:30 pm
A Case-Control Study of Mercury Burden in Children with Autistic Disorders and Measles Virus Genomic RNA in Cerebrospinal Fluid in Children with Regressive Autism
Jeff Bradstreet, M.D., FAAFP, Adjunct Professor, Neurosciences, Stetson University, Director of Clinical Programs, International Child Development Resource Center, Florida
4:30–5:00 pm
Autism, Vaccines, and Immune Reactions
Vijendra K. Singh, Ph.D., Research Associate Professor, Utah State University
5:00–5:30 pm
Public Comment Period
5:30 pm
Adjourn
